Zentalis Pharmaceuticals, Inc.

ZNTLNasdaq· Pharmaceutical Preparations

Price History

Revenue

$67.4M

Net Income

-$165.8M

▲ 43.2% YoY

EPS

$-2.33

▲ 47.9% YoY

Cash

$33.9M

▲ 20.9% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.